Nocturnal Gamma-Hydroxybutyrate Reduces Cortisol-Awakening Response and Morning Kynurenine Pathway Metabolites in Healthy Volunteers

BACKGROUND: Gamma-hydroxybutyrate (GHB; or sodium oxybate) is an endogenous GHB-/gamma-aminobutyric acid (B) receptor agonist. It is approved for application in narcolepsy and has been proposed for the potential treatment of Alzheimer’s disease, Parkinson’s disease, fibromyalgia, and depression, all...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Int J Neuropsychopharmacol
Hlavní autoři: Dornbierer, D A, Boxler, M, Voegel, C D, Stucky, B, Steuer, A E, Binz, T M, Baumgartner, M R, Baur, D M, Quednow, B B, Kraemer, T, Seifritz, E, Landolt, H P, Bosch, O G
Médium: Artigo
Jazyk:Inglês
Vydáno: Oxford University Press 2019
Témata:
Regular Research Articles
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6822136/
https://ncbi.nlm.nih.gov/pubmed/31504554
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ijnp/pyz047
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky